{"id":"W6902110175","doi":"10.6084/m9.figshare.13177494.v1","title":"Cost-utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Rituximab; Infliximab; Adalimumab; Etanercept; Rheumatoid arthritis; TNF inhibitor; Rheumatology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007351799,0.001097779,0.001882101,0.001600821,0.0002908741,0.001761315,0.001409498,0.001123006,0.002797908],"category_scores_gemma":[0.02315899,0.000671006,0.003938328,0.00151448,0.0004862937,0.0007437231,0.0007585909,0.001276009,0.0001725847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01425551,"about_ca_system_score_gemma":0.004494028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09508669,"about_ca_topic_score_gemma":0.05105493,"domain_scores_codex":[0.9955384,0.003429946,0.000145665,0.0002745002,0.0003370121,0.0002744342],"domain_scores_gemma":[0.9837721,0.01367423,0.001087036,0.0002783171,0.0007568374,0.0004314691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.009567091,0.0004991309,0.02490642,0.0004946059,0.004020383,0.0002322918,0.00005482408,0.9472013,0.0004633947,0.002043693,0.0007292115,0.009787716],"study_design_scores_gemma":[0.001249913,0.002083644,0.02252621,0.0002090589,0.002569885,0.0001922619,0.00008472124,0.9682376,0.0004247607,0.001458295,0.0008858864,0.00007791322],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9739885,0.008414059,0.009018132,0.0009241992,0.00005633389,0.0006609182,0.00360218,0.00006330933,0.0032724],"genre_scores_gemma":[0.9959651,0.0006010443,0.001932872,0.0001130803,0.00001181054,0.0001344029,0.0007559099,0.000008648122,0.0004770193],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09508669,"threshold_uncertainty_score":0.1890665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07118231827534927,"score_gpt":0.3040545866416625,"score_spread":0.2328722683663132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}